PL3240772T3 - Związki z antrodia camphorata, sposoby ich otrzymywania i ich zastosowanie - Google Patents
Związki z antrodia camphorata, sposoby ich otrzymywania i ich zastosowanieInfo
- Publication number
- PL3240772T3 PL3240772T3 PL15875258T PL15875258T PL3240772T3 PL 3240772 T3 PL3240772 T3 PL 3240772T3 PL 15875258 T PL15875258 T PL 15875258T PL 15875258 T PL15875258 T PL 15875258T PL 3240772 T3 PL3240772 T3 PL 3240772T3
- Authority
- PL
- Poland
- Prior art keywords
- anthrodia
- camphorata
- obtaining
- relationship
- methods
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C69/00—Esters of carboxylic acids; Esters of carbonic or haloformic acids
- C07C69/02—Esters of acyclic saturated monocarboxylic acids having the carboxyl group bound to an acyclic carbon atom or to hydrogen
- C07C69/12—Acetic acid esters
- C07C69/21—Acetic acid esters of hydroxy compounds with more than three hydroxy groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C49/00—Ketones; Ketenes; Dimeric ketenes; Ketonic chelates
- C07C49/587—Unsaturated compounds containing a keto groups being part of a ring
- C07C49/753—Unsaturated compounds containing a keto groups being part of a ring containing ether groups, groups, groups, or groups
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
- A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/06—Fungi, e.g. yeasts
- A61K36/07—Basidiomycota, e.g. Cryptococcus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C45/00—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
- C07C45/61—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups
- C07C45/64—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by introduction of functional groups containing oxygen only in singly bound form
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C45/00—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
- C07C45/78—Separation; Purification; Stabilisation; Use of additives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C45/00—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
- C07C45/78—Separation; Purification; Stabilisation; Use of additives
- C07C45/79—Separation; Purification; Stabilisation; Use of additives by solid-liquid treatment; by chemisorption
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C49/00—Ketones; Ketenes; Dimeric ketenes; Ketonic chelates
- C07C49/527—Unsaturated compounds containing keto groups bound to rings other than six-membered aromatic rings
- C07C49/577—Unsaturated compounds containing keto groups bound to rings other than six-membered aromatic rings containing ether groups, groups, groups, or groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C67/00—Preparation of carboxylic acid esters
- C07C67/48—Separation; Purification; Stabilisation; Use of additives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C67/00—Preparation of carboxylic acid esters
- C07C67/48—Separation; Purification; Stabilisation; Use of additives
- C07C67/56—Separation; Purification; Stabilisation; Use of additives by solid-liquid treatment; by chemisorption
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
- C07D307/26—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
- C07D307/30—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D307/32—Oxygen atoms
- C07D307/33—Oxygen atoms in position 2, the oxygen atom being in its keto or unsubstituted enol form
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2601/00—Systems containing only non-condensed rings
- C07C2601/12—Systems containing only non-condensed rings with a six-membered ring
- C07C2601/16—Systems containing only non-condensed rings with a six-membered ring the ring being unsaturated
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Mycology (AREA)
- Epidemiology (AREA)
- Microbiology (AREA)
- Engineering & Computer Science (AREA)
- Medical Informatics (AREA)
- Botany (AREA)
- Biotechnology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Alternative & Traditional Medicine (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Emergency Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Plant Substances (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201462098177P | 2014-12-30 | 2014-12-30 | |
| EP15875258.4A EP3240772B1 (en) | 2014-12-30 | 2015-12-30 | Compounds from antrodia camphorata, method for preparing the same and use thereof |
| PCT/CN2015/099894 WO2016107582A1 (en) | 2014-12-30 | 2015-12-30 | Compounds from antrodia camphorata, method for preparing the same and use thereof |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PL3240772T3 true PL3240772T3 (pl) | 2021-06-28 |
Family
ID=56163420
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL15875258T PL3240772T3 (pl) | 2014-12-30 | 2015-12-30 | Związki z antrodia camphorata, sposoby ich otrzymywania i ich zastosowanie |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US9884801B2 (pl) |
| EP (1) | EP3240772B1 (pl) |
| JP (1) | JP6896630B2 (pl) |
| CN (1) | CN105732381B (pl) |
| ES (1) | ES2869904T3 (pl) |
| MY (1) | MY173104A (pl) |
| PL (1) | PL3240772T3 (pl) |
| TW (1) | TWI648257B (pl) |
| WO (1) | WO2016107582A1 (pl) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN106063800B (zh) * | 2016-08-01 | 2020-02-18 | 上海交通大学 | 牛樟芝在抗前列腺增生药物中的应用 |
| EP3541777B1 (en) * | 2016-11-18 | 2023-01-11 | Golden Biotechnology Corporation | Compositions for treating atopic dermatitis |
| CN108409571A (zh) * | 2018-03-23 | 2018-08-17 | 中国药科大学 | 从金刚纂中提取的用于治疗癌症的化合物 |
| CN113795258B (zh) * | 2019-02-25 | 2024-04-16 | 吉亚生技控股股份有限公司 | 抑制病毒感染的方法及组合物 |
| CN112851510B (zh) * | 2021-01-27 | 2022-07-19 | Ａｇｃ株式会社 | 他氟前列素的纯化方法 |
| CN113831221B (zh) * | 2021-09-18 | 2023-04-07 | 云南民族大学 | 一种倍半萜类化合物及其制备方法与应用 |
| CN114487252B (zh) * | 2021-12-28 | 2024-03-26 | 陕西嘉禾生物科技股份有限公司 | 一种用于区别牛樟芝和牛樟木的薄层色谱鉴别方法 |
Family Cites Families (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6247838B1 (en) | 1998-11-24 | 2001-06-19 | The Boc Group, Inc. | Method for producing a liquid mixture having a predetermined concentration of a specified component |
| US7531627B2 (en) | 2003-12-19 | 2009-05-12 | Po-Jung Chien | Protein ACA1 of Antrodia camphorata |
| US7109232B2 (en) | 2004-03-08 | 2006-09-19 | Simpson Biotech Co., Ltd. | Compounds from Antrodia camphorata having anti-inflammatory and anti-tumor activity |
| ATE513823T1 (de) | 2004-08-17 | 2011-07-15 | Simpson Biotech Co Ltd | Mischung und verbindungen von mycelien von antrodia camphorata und deren verwendung |
| US7601854B2 (en) | 2006-10-25 | 2009-10-13 | Kang Jian Biotech Corp., Ltd. | Diterpenes from the fruiting body of Antrodia camphorata and pharmaceutical compositions thereof |
| TW200829234A (en) * | 2007-01-08 | 2008-07-16 | Golden Biotechnology Corp | Antrodia camphorata isophorone extract |
| TW200918498A (en) | 2007-10-19 | 2009-05-01 | Golden Biotechnology Corp | Novel compound isolated from Antrodia camphorate extracts |
| CN101417934B (zh) * | 2007-10-24 | 2012-04-18 | 国鼎生物科技股份有限公司 | 分离自牛樟芝萃取物的化合物 |
| TW201000112A (en) | 2008-06-18 | 2010-01-01 | Mackay Memorial Hospital | Use of dehydrosulphurenic acid for inhibiting the growth of cancer cells |
| US8309611B2 (en) * | 2010-09-20 | 2012-11-13 | Golden Biotechnology Corporation | Methods and compositions for treating lung cancer |
| CN103796647A (zh) * | 2011-06-10 | 2014-05-14 | 国鼎生物科技股份有限公司 | 用于治疗脑癌的方法和组合物 |
| CN103570531A (zh) * | 2012-07-25 | 2014-02-12 | 丽丰实业股份有限公司 | 樟芝菌丝体的化合物及其用途 |
| JP5908002B2 (ja) * | 2013-03-20 | 2016-04-26 | 卉菱 曽 | ベニクスノキタケに含まれる化合物及びその用途 |
| TWI583376B (zh) * | 2013-03-20 | 2017-05-21 | 曾卉菱 | Compounds isolated from Antelroxicus and their use |
| CN104177240B (zh) * | 2013-05-28 | 2016-10-19 | 曾卉菱 | 分离自牛樟芝的化合物、萃取物及其用途 |
| CN104211627A (zh) * | 2013-05-29 | 2014-12-17 | 曾卉菱 | 牛樟芝化合物、萃取物及其用途 |
| US9249117B2 (en) * | 2014-05-20 | 2016-02-02 | Hui Ling Tseng | Use of compounds from Antrodia camphorata in manufacturing medicaments for treating kidney diseases |
-
2015
- 2015-12-30 US US14/984,442 patent/US9884801B2/en active Active
- 2015-12-30 EP EP15875258.4A patent/EP3240772B1/en active Active
- 2015-12-30 TW TW104144385A patent/TWI648257B/zh active
- 2015-12-30 PL PL15875258T patent/PL3240772T3/pl unknown
- 2015-12-30 ES ES15875258T patent/ES2869904T3/es active Active
- 2015-12-30 WO PCT/CN2015/099894 patent/WO2016107582A1/en not_active Ceased
- 2015-12-30 MY MYPI2017702368A patent/MY173104A/en unknown
- 2015-12-30 JP JP2017535086A patent/JP6896630B2/ja active Active
- 2015-12-30 CN CN201511023602.XA patent/CN105732381B/zh active Active
Also Published As
| Publication number | Publication date |
|---|---|
| TWI648257B (zh) | 2019-01-21 |
| EP3240772A1 (en) | 2017-11-08 |
| JP2018507175A (ja) | 2018-03-15 |
| CN105732381B (zh) | 2021-07-20 |
| JP6896630B2 (ja) | 2021-06-30 |
| TW201623208A (zh) | 2016-07-01 |
| MY173104A (en) | 2019-12-26 |
| WO2016107582A1 (en) | 2016-07-07 |
| EP3240772B1 (en) | 2021-03-03 |
| US9884801B2 (en) | 2018-02-06 |
| EP3240772A4 (en) | 2018-08-29 |
| US20160185703A1 (en) | 2016-06-30 |
| ES2869904T3 (es) | 2021-10-26 |
| CN105732381A (zh) | 2016-07-06 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL304772A (en) | Antibodies, uses and methods | |
| IL249639A0 (en) | Endophytes, associated compositions, and methods of use thereof | |
| IL259747A (en) | Antibodies targeting fc receptor-like 5 and methods of use | |
| IL254039A0 (en) | Anti-pvrig antibodies and methods of use | |
| IL258826A (en) | Liver-specific constructs, factor viii expression cassettes and methods of use thereof | |
| IL254458B (en) | Anti-pdl1 antibodies, activatable anti-pdl1 antibodies, and methods of use thereof | |
| IL251970B (en) | Anti-cd79b antibodies and methods of use | |
| PL3353210T3 (pl) | Przeciwciała anty-TIGIT i sposoby stosowania | |
| DK3283511T3 (da) | Modified collagen, methods of manufacture thereof | |
| PL3167096T3 (pl) | Dwuetapowy sposób nanoszenia | |
| PL3325443T3 (pl) | Sposób otrzymywania pridopidyny | |
| PL3215532T3 (pl) | Przeciwciała anty-TIM3 i sposoby ich zastosowania | |
| HUE052373T2 (hu) | Szubsztituált krománok és alkalmazási eljárások | |
| EP3461890C0 (en) | TOTAL FERMENTATION OF OLIGOSACCHARIDES | |
| DK3201351T3 (da) | Kaloriefrie sødestoffer og fremgangsmåder til syntetisering | |
| LT3628680T (lt) | Komplemento aktyvumo moduliavimas | |
| PL3148579T3 (pl) | Przeciwciała anty-gitr i sposoby ich zastosowania | |
| PL3250610T3 (pl) | Przeciwciała anty-FcRn i sposoby ich stosowania | |
| IL272851A (en) | Methods of using dipivefrin | |
| IL254670A0 (en) | Humanized anti-c1s antibodies and methods of use thereof | |
| HUE054093T2 (hu) | Anti-HtrA1 antitestek és azok alkalmazási eljárásai | |
| LT3237432T (lt) | Baltymo gamyba | |
| DK3374495T3 (da) | Forbedrede fremgangsmåder til vævsfremstilling | |
| HUE056544T2 (hu) | Gamma-C-citokin aktivitás modulálása | |
| DK3225627T5 (da) | Tripeptidforbindelse, fremgangsmåde til fremstilling deraf og anvendelse deraf |